![Cancer genomic testing | Jennifer’s story unnamed 7 unnamed 7](https://clinicalvalue.com/wp-content/uploads/2023/04/unnamed-7.png)
Cancer genomic testing | Jennifer’s story
Comprehensive genomic profiling (CGP) is a method of cancer genomic testing used to reveal the unique set of mutations within the cancer’s DNA which determine how…
READ MOREYou are about to leave the Clinical Value website now.
Comprehensive genomic profiling (CGP) is a method of cancer genomic testing used to reveal the unique set of mutations within the cancer’s DNA which determine how…
READ MOREIn this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root.
READ MOREIn this article, Prof Jee Hyun Kim explains her clinical experiences of NGS, and how she sees it evolving within South Korea’s innovative healthcare ecosystem.
READ MOREWhile precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of…
READ MOREThis whitepaper shares recommendations on ensuring standardization and quality of NGS across the region, to realize the potential of NGS and establish more effective and market-appropriate…
READ MOREThe NCCN Guidelines are a comprehensive set of guidelines detailing the sequential management decisions and interventions to assist in the decision-making process of individuals involved in…
READ MOREThese recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
READ MORE